Credit Suisse Upgrades St Jude Medical To Neutral

Analysts at Credit Suisse upgraded St Jude Medical Inc. STJ from Underperform to Neutral. The price target for St Jude Medical is set to $74. St Jude Medical shares have surged 8.98% over the past 52 weeks, while the S&P 500 index has gained 14.83% in the same period. St Jude Medical shares rose 0.34% to close at $68.17 on Friday.